AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitagliptin M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Knoll Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitagliptin M 50mg/500mg Tablet

The dual-action tablet, Sitagliptin M 50mg/500mg, manages elevated blood glucose in type 2 diabetes patients. This dual therapy mitigates severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risks (heart attack or stroke). This medication might be prescribed independently or in conjunction with other antidiabetic treatments. Optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Consuming it with meals minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical guidance. Maintaining the prescribed diet and exercise plan is crucial for comprehensive diabetes management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Concurrent use with insulin or sulfonylureas increases hypoglycemia risk; appropriate management strategies should be understood. This medication isn't universally suitable. Prior kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption necessitate physician consultation before initiation. Pregnant or lactating individuals require medical evaluation. Interactions with other medications are possible; therefore, full disclosure of all medications is essential for patient safety. Alcohol should be limited due to its hypoglycemic effect. Renal function and blood glucose monitoring are conducted before, during, and after treatment.

Primary Ingredients of Sitagliptin M 50mg/500mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Sitagliptin M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitagliptin M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Sitagliptin M 50mg/500mg tablet should be administered with a meal.

Common Side effects of Sitagliptin M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitagliptin M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Sitagliptin M 50mg/500mg Tablet should be administered with a meal.

How Sitagliptin M 50mg/500mg Tablet works:

Januvia Metformin 50mg/500mg tablets combine sitagliptin and metformin to improve blood glucose management. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitagliptin M 50mg/500mg tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitagliptin M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice from your doctor.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitagliptin M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitagliptin M 50mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. The medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Sitagliptin M 50mg/500mg tablets due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Sitagliptin M 50mg/500mg Tablet :

Should you forget a Sitagliptin M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitagliptin M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitagliptin M 50mg/500mg Tablet

Sitagliptin/Metformin 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitagliptin M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitagliptin 50mg/500mg tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitagliptin M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitagliptin M 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from high blood lactic acid levels (also known as MALA – Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Sitagliptin/Metformin 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitagliptin 50mg/500mg tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitagliptin M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining alcohol and Sitagliptin M 50mg/500mg tablets is unsafe due to an increased risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitagliptin M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Sitagliptin-Metformin 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sitagliptin M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitagliptin M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitagliptin M 50mg/500mg tablets is unsafe due to the increased risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also called Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol, thus metformin is avoided in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitagliptin M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. Preventive annual vitamin B12 supplementation is suggested by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Sitagliptin M 50mg/500mg ...
104
MRP 121
14% off